amphetamine has been researched along with pyrrolidine-2,4-dicarboxylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, JD; Kim, JH; Perugini, M; Vezina, P | 1 |
| Abraini, JH; David, HN; Thévenoux, A | 1 |
2 other study(ies) available for amphetamine and pyrrolidine-2,4-dicarboxylic acid
| Article | Year |
|---|---|
Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Dicarboxylic Acids; Dopamine Agonists; Drug Administration Schedule; Drug Synergism; Excitatory Amino Acid Agents; Glutamic Acid; Male; Microinjections; Motor Activity; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Time | 2001 |
Inhibition of the glutamate transporter by L-trans-PDC in the nucleus accumbens prevents the locomotor response to amphetamine.
Topics: Amino Acid Transport System X-AG; Amphetamine; Animals; Central Nervous System Stimulants; Dicarboxylic Acids; Injections; Male; Motor Activity; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Sprague-Dawley | 2001 |